About Daniel Wee
Form D filings for Enveda Therapeutics in 2023 list Daniel Wee as executive officer.
Daniel Wee first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name Daniel Wee in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Daniel Wee works with at each company, as listed on that company's latest Form D.
Enveda Therapeutics, Inc. · Form D, Mar 7, 2023
RS
Rohit Sharma
Director
ZD
Zavain Dar
Director
BB
Bruce Beutel
Director
SV
Shaquille Vayda
Director
VC
Viswa Colluru
Chief Executive Officer and director